60 Degrees Pharmaceuticals, Inc.
SXTPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Other share classesSXTP
Q3 2023 vs. Q2 2023
How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 8 | +8 |
| Shares | 0 | 743.2K | +743.2K |
| Value | $0 | $261.0K | +$261.0K |
New holders (8)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 306,717 | $107.4K | 0.34% |
| Walleye Capital LLC | 222,906 | $78.0K | 0.00% |
| Clear Street LLC | 152,582 | $53.4K | 0.00% |
| Warberg Asset Management LLC | 29,515 | $10.3K | 0.00% |
| Virtu Financial LLC | 20,301 | $8.00K | 0.00% |
| UBS Group AG | 6,065 | $2.12K | 0.00% |
| Federation des caisses Desjardins du Quebec | 5,000 | $1.75K | 0.00% |
| Bank of America Corp | 100 | $35 | 0.00% |
Sold out (0)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.